Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-12 Purchase | 2024-09-17 7:48 pm | Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director | 476,190 | $10.5 | $4,999,995 | 476,190 (Indirect) | View |
2024-09-10 Sale | 2024-09-12 6:10 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 10,000 | $11 | $110,000 | 146,940 (Direct) | View |
2024-09-09 Sale | 2024-09-11 6:00 pm | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 17,235 | $10 | $172,350 | 15,000 (Direct) | View |
2024-08-01 Sale | 2024-08-05 8:11 pm | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 15,000 | $7.572 | $113,580 | 15,000 (Direct) | View |
2024-07-15 Sale | 2024-07-17 8:53 pm | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 56,164 | $10 | $561,640 | 755,635 (Indirect) | View |
2024-07-15 Sale | 2024-07-17 8:48 pm | Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC Director 10% Owner | 56,164 | $10 | $561,640 | 755,635 (Indirect) | View |
2024-07-15 Sale | 2024-07-17 7:56 pm | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 14,765 | $10 | $147,660 | 64,870 (Direct) | View |
2024-05-31 Purchase | 2024-06-04 6:06 pm | Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan COO and General Counsel | 4,791 | $4.44 | $21,272 | 91,940 (Direct) | View |
2024-05-31 Purchase | 2024-06-04 6:05 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 4,791 | $4.44 | $21,272 | 91,940 (Direct) | View |
2024-04-01 Sale | 2024-04-03 8:47 pm | Terns Pharmaceuticals Inc. | TERN | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 420,663 | $6.6487 | $2,796,859 | 268,573 (Indirect) | View |
2023-11-30 Purchase | 2023-12-04 6:03 pm | Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan COO and General Counsel | 743 | $3.78 | $2,809 | 18,399 (Direct) | View |
2023-11-30 Purchase | 2023-12-04 6:03 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 743 | $3.78 | $2,809 | 18,399 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-11-18 Option Award | 2024-11-19 6:30 pm | N/A 2034-11-17 | Terns Pharmaceuticals Inc. | TERN | Turner Heather D Director | 64,000 | $0 | 64,000 (Direct) | View |
2024-09-10 Exercise | 2024-09-12 6:10 pm | N/A 2032-01-25 | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 10,000 | $0 | 146,940 (Direct) | View |
2024-09-10 Exercise | 2024-09-12 6:10 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 10,000 | $5.36 | 146,940 (Direct) | View |
2024-09-09 Exercise | 2024-09-11 6:00 pm | 2023-06-12 2032-06-15 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 17,235 | $0 | 15,000 (Direct) | View |
2024-09-09 Exercise | 2024-09-11 6:00 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 17,235 | $1.82 | 15,000 (Direct) | View |
2024-07-15 Exercise | 2024-07-17 7:56 pm | 2023-06-12 2032-06-15 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 14,765 | $0 | 64,870 (Direct) | View |
2024-07-15 Exercise | 2024-07-17 7:56 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 14,765 | $1.82 | 64,870 (Direct) | View |
2024-07-01 Option Award | 2024-07-02 6:38 pm | N/A 2034-06-30 | Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director | 4,676 | $0 | 4,676 (Direct) | View |
2024-07-01 Option Award | 2024-07-02 6:37 pm | N/A 2034-06-30 | Terns Pharmaceuticals Inc. | TERN | Taylor Ann Elizabeth Director | 4,676 | $0 | 4,676 (Direct) | View |
2024-07-01 Option Award | 2024-07-02 6:36 pm | N/A 2034-06-30 | Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director | 4,676 | $0 | 4,676 (Direct) | View |
2024-07-01 Option Award | 2024-07-02 6:36 pm | N/A 2034-06-30 | Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director | 4,676 | $0 | 4,676 (Direct) | View |
2024-07-01 Option Award | 2024-07-02 6:36 pm | N/A 2034-06-30 | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 4,676 | $0 | 4,676 (Direct) | View |
2024-07-01 Option Award | 2024-07-02 6:36 pm | N/A 2034-06-30 | Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director | 8,183 | $0 | 8,183 (Direct) | View |
2024-06-10 Option Award | 2024-06-14 6:05 pm | N/A 2034-06-09 | Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director | 32,000 | $0 | 32,000 (Direct) | View |
2024-06-10 Option Award | 2024-06-14 6:05 pm | N/A 2034-06-09 | Terns Pharmaceuticals Inc. | TERN | Taylor Ann Elizabeth Director | 32,000 | $0 | 32,000 (Direct) | View |
2024-06-10 Option Award | 2024-06-14 6:04 pm | N/A 2034-06-09 | Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director | 32,000 | $0 | 32,000 (Direct) | View |
2024-06-10 Option Award | 2024-06-14 6:04 pm | N/A 2034-06-09 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 32,000 | $0 | 32,000 (Direct) | View |
2024-06-10 Option Award | 2024-06-14 6:04 pm | N/A 2034-06-09 | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 32,000 | $0 | 32,000 (Direct) | View |
2024-06-10 Option Award | 2024-06-14 6:04 pm | N/A 2034-06-09 | Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director | 32,000 | $0 | 32,000 (Direct) | View |
2024-06-10 Option Award | 2024-06-14 6:03 pm | N/A 2034-06-09 | Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director | 32,000 | $0 | 32,000 (Direct) | View |
2024-05-01 Option Award | 2024-05-02 5:29 pm | N/A 2034-04-30 | Terns Pharmaceuticals Inc. | TERN | Jung Melita Sun Chief Business Officer | 475,000 | $0 | 475,000 (Direct) | View |
Ownership | 2024-03-19 7:26 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 0 | $0 | 456,250 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 6:01 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 1,400,000 | $0 | 1,400,000 (Direct) | View |
2024-01-23 Option Award | 2024-01-25 7:18 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Sr. Advisor & Strategy Officer | 15,000 | $0 | 30,000 (Direct) | View |
2024-01-23 Option Award | 2024-01-25 7:18 pm | N/A 2034-01-22 | Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan COO and General Counsel | 206,250 | $0 | 224,649 (Direct) | View |
2024-01-23 Option Award | 2024-01-25 7:17 pm | N/A 2034-01-22 | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 206,250 | $0 | 224,649 (Direct) | View |
2024-01-23 Option Award | 2024-01-25 7:17 pm | N/A 2034-01-22 | Terns Pharmaceuticals Inc. | TERN | Quirk Erin President, Head of R&D | 225,000 | $0 | 225,000 (Direct) | View |
2023-11-15 Option Award | 2023-11-17 6:10 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Sr. Advisor & Strategy Officer | 15,000 | $0 | 15,000 (Direct) | View |
2023-06-12 Option Award | 2023-06-14 7:02 pm | N/A 2033-06-11 | Terns Pharmaceuticals Inc. | TERN | Taylor Ann Elizabeth Director | 32,000 | $0 | 32,000 (Direct) | View |
2023-06-12 Option Award | 2023-06-14 7:02 pm | N/A 2033-06-11 | Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director | 32,000 | $0 | 32,000 (Direct) | View |
2023-06-12 Option Award | 2023-06-14 7:02 pm | N/A 2033-06-11 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 32,000 | $0 | 32,000 (Direct) | View |